Mussa Banisadre in Stockton, California

Home California Stockton

Mussa Banisadre has Hematology as his primary medical specialty. Their primary office is: 2626 N California St in Stockton, California. There are 2 additional office locations for Mussa Banisadre that can be viewed towards the end of their profile.

They're a part of the: Stockton Hematology Oncology Medical Group Inc medical group which has around 8 members. You can call their office at 209-466-2626 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1973 (around 51 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mussa Banisadre Office Phone and Directions

Mussa Banisadre
Stockton Hematology Oncology Medical Group Inc
2626 N California St
Stockton, California 95204
209-466-2626

Patient Ratings
Please rate your experience with Mussa Banisadre below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 209-466-2626

Enter a starting address:

Healthcare Info for Mussa Banisadre

Medical School: Sorry, his university is not listed
Graduation Year: 1973
The Primary Medical Specialty for Mussa Banisadre is listed as: Hematology
Approximate Years of Experience: 51
PAC (PECOS ID)#: 7315907524
NPI #: 1043264690
NPI Created On: 05/19/2006
NPI Last Updated Listed as: 04/14/2008
Primary Taxonomy Code: 207RH0003X
License Number:
A38740
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, heparin sodium, (heparin lock flush), per 10 units
Injection, ondansetron hydrochloride, per 1 mg
Infusion, normal saline solution, 250 cc

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788963743

Being Disputed:: No

Product Related: No

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788963745

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788963749

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788963747

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ERLEADA

Associated Drug #2: 59676-600-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788963751

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008151

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008153

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008155

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793978705

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Additional Office Locations

1. Stockton Hematology Oncology Medical Group Inc
801 S Ham Ln
Lodi, CA 95242
Suite S
Group Members: 8

Phone: 209-466-2626

Enter a starting address:

2. Stockton Hematology Oncology Medical Group Inc
1325 Melrose Ave
Modesto, CA 95350
Suite A
Group Members: 8

Phone: 209-466-2626

Enter a starting address:

Hematology Professionals in Stockton

1.
Christine Kaiser

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

2.
John Kiraly MD

2626 N California St
Stockton, CA
Stockton Hematology Oncology Medical Group Inc

3.
Ming Zhou

2505 W Hammer Ln
Stockton, CA
Sutter Valley Medical Foundation

4.
Ming Zhou

2545 W Hammer Ln
Stockton, CA
Sutter Valley Medical Foundation

5.
Neelesh Bangalore MD

2626 N California St
Stockton, CA
Stockton Hematology Oncology Medical Group Inc

Providers in Stockton Hematology Oncology Medical Group Inc

1.Neelesh Bangalore Md

2626 N California St
Stockton Ca 95204-5500
Stockton Hematology Oncology Medical Group Inc
Hematology

2.Neelesh Bangalore Md

801 S Ham Ln
Lodi Ca 95242-7503
Stockton Hematology Oncology Medical Group Inc
Hematology

3.Neelesh Bangalore Md

300 Northgate Dr
Manteca Ca 95336-3139
Stockton Hematology Oncology Medical Group Inc
Hematology

4.Neelesh Bangalore Md

1325 Melrose Ave
Modesto Ca 95350-5581
Stockton Hematology Oncology Medical Group Inc
Hematology

5.Neelesh Bangalore Md

2316 Orchard Pkwy
Tracy Ca 95377-7324
Stockton Hematology Oncology Medical Group Inc
Hematology

6.Mussa Banisadre

2626 N California St
Stockton Ca 95204-5500
Stockton Hematology Oncology Medical Group Inc
Hematology

View all 8 members of Stockton Hematology Oncology Medical Group Inc medical group